Exhibit 16.1
March 19, 2015
U.S. Securities and Exchange Commission
Office of the Chief Accountant
100 F Street, NE
Washington, DC 20549
Re: Medytox Solutions, Inc.
File No. 000-54346
Dear Sir or Madam:
We have read Item 4.01 of Form 8-K of Medytox Solutions, Inc. dated March 19, 2015, and agree with the statements concerning our Firm contained therein.
Very truly yours,
/s/ Grant Thornton LLP